Results
9
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ABT New | CHF 93.50 | 0% | 0.5% | CHF 197.4b | CHF 107.22 | PE34.4x | E11.6% | 2.1% | ||
020259063 | CHF 109.67 | 0% | -4.6% | CHF 185.4b | CHF 117.61 | PE39.4x | E10.2% | 2.3% | ||
STMN | CHF 112.90 | -1.7% | -12.2% | CHF 18.0b | CHF 131.00 | PE62.5x | E21.2% | 0.8% | ||
YPSN | CHF 338.00 | 0.1% | 14.4% | CHF 4.6b | CHF 420.00 | PE62x | E40.1% | 0.6% | ||
LEPU | US$18.00 | 0% | 10.4% | US$20.0b | US$23.39 | PE28.3x | E28.2% | 2.6% | ||
MOVE | CHF 110.20 | 1.7% | -10.0% | CHF 2.2b | CHF 139.84 | PE41.8x | E21.1% | 0.5% | ||
MED | CHF 57.70 | -3.2% | -26.2% | CHF 784.5m | CHF 102.47 | PE194.6x | E53.9% | n/a | ||
MEDX New | CHF 9.14 | 4.8% | -50.5% | CHF 372.8m | CHF 25.00 | PS0.8x | E59.6% | 5.5% | ||
CLTN | CHF 50.80 | -0.8% | -25.7% | CHF 303.5m | CHF 62.50 | PE24.6x | E22.3% | 3.9% |